Over the projection period, the worldwide surgical gowns market is estimated to increase at a CAGR of 3.16% to reach US$1,090.617 million by 2027, up from US$904.798 million in 2021.
Surgical gowns are worn by doctors during surgery. The surgeons and assisting personnel wear it for hygiene reasons. One of the most essential tasks of surgical gowns is to keep patients from contracting potentially fatal Hospital Acquired Infections (HAIs). With recent developments in medical facilities, public awareness of hospital-acquired illnesses has grown. Surgical gowns keep germs and other microbes from entering the person operating on the patient. Surgical gowns serve as a barrier against microbial infection in the operating room. The surgical gown aids in the control of bacteria transmission and disease spread. Furthermore, the rising prevalence of chronic illnesses will impact the market share positively. The International Diabetes Federation [IDF] predicts that 700 million persons worldwide will get diabetes by 2045.
Major advancements in the healthcare sector, expanding hospital and healthcare facility establishments, a rise in the number of surgeries combined with innovation in medical safety clothing, and a quickly growing aging people are the major factors driving market demand for surgical gowns and propelling their market growth.
The increase in surgical cases is likely to propel the expansion of the surgical gowns market over the forecast period. Additionally, the rise in the occurrence of hospital-acquired infections is expected to fuel the expansion of the surgical gown industry. Moreover, the increased awareness of hospital-related infections is expected to buffer the expansion of the surgical gown demand.
The rising developments in the healthcare sector will boost the market share in the upcoming years.
The healthcare segment is anticipated to grow which will positively influence the market size during the projected period. With the rising developments in the medical sector, the market for global surgical gowns is expected to surge. For instance, MEDU, a firm located in Mexico, aims to minimize waste and replace single-use medical clothing by developing a range of sustainable, virus-resistant recyclable products such as surgical gowns, head covers, and full-body suits. With an initial $400,000 investment, the business began trials in Mexican hospitals to evaluate and certify the findings and determine if doctors liked wearing the goods. The business hopes to substitute over 20 million single-use PPE garments and remove 6,000 tonnes of hospital trash from incinerators or landfills by the end of 2022. Furthermore, the firm has more than doubled in size and is now collaborating with institutions in Los Angeles and New York.
Additionally, Medtecs International Corporation Limited announced in November 2022 that two of the company’s popular disposable gowns, CoverU Disposable Gowns with Tape AAMI Level 4 Isolation Gown and CoverU Disposable Gowns with Tape – Chemo Gown, received 510(k) clearance from the United States Food and Drug Administration (FDA), confirming the safety and effectiveness of Medtecs’ products. The results came after a thorough analysis of the gowns’ performance data to confirm that both met all FDA criteria. It is also the first time a Taiwanese PPE brand received authorization in the United States for isolation and chemo gowns at the greatest degree of protection. Therefore, such market developments and initiatives taken by the government will propel the market to grow.
The introduction of new products by numerous firms will increase market size during the projected period.
Due to the launch of new products, healthcare companies have extended their operations which is projected to be lucrative for the market revenue and profitability.
For instance, RJ Group, a manufacturer and supplier of hospitality items, entered the healthcare market in July 2022 with the release of its SSMMS & REUSABLE PPE Kit. In this sector, the business provides a variety of safety items for medical personnel such as coverall suits, surgical gowns, doctor’s gowns, ICU coveralls, and doctor’s aprons. These kits also include SITRA-approved PPE Fabrics and meet FDA, CE, and ISO 13485 quality requirements. These kits are made of Tyvek fabric from DUPONT, the world’s leading safety gear producer, as well as Jindal fabric from India and other prominent fabric producers.
Similarly, in March 2022, Invenio introduced a new surgical gown line, the V90 surgical gown series. It has a lot of features, like sonic welds throughout, comfortable knit cuffs, and a large hook and loop fastening for adjustment and complete coverage. It provides non-reinforced, fabric-reinforced, and film-reinforced performance choices, allowing the user to choose the best gown for the surgery.
Furthermore, companies have signed partnership agreements with other firms to expand their business operations which has led the market to grow. For instance, Medline and 3M, for example, partnered in December 2021 to standardize surgical warming robes. Making normothermia the standard of care for all patients decreases post-operative surgical site infections (SSIs) and consequences.
During the forecast period, the global surgical gown market in North America is predicted to have a dominating share.
The global surgical gown market is divided into five areas based on geography: North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. Hospital gown demand in North America is expected to climb as the number of operations and healthcare professionals increases. Moreover, rising hospital-acquired illnesses are expected to push product demand even further. According to the most recent National Center for Health Statistics data, the United States completed around 48 million surgical inpatient treatments. Cardinal Health, a significant maker of surgical gowns, advised clients in January 2020 to discontinue the use of its Level 3 surgical gowns and the procedural packs that included the gowns. Some of the gowns were created in “unapproved sites that did not maintain a suitable state of the environment as required by law, were not recognized with the United States Food and Drug Administration (FDA), and were not certified by Cardinal Health,” according to the business. The recall is voluntary, and the FDA is not aware of any patients being injured as a result of surgical gowns. More than 9 million gowns are involved in the recall, with 7.7 million sent to 2,807 hospitals across the US.